CERC-ASIA PTE LTD
CERC-Asia is the new Asian subsidiary of CERC, a reputable high-quality dedicated CRO in Europe founded by KOL in Interventional Cardiovascular medicine.
Since 2008,CERC-Europe has achieved an excellent track record in regulatory guidance, trial design, strategic planning, global study management and monitoring, and provides support for communication and publications in major congresses and journals.
Over the past few years CERC-Europe has already successfully conducted clinical trials in Asia.
Driven by CERC’s wide experience in cardiovascular research CERC-Asia has been conceived with the aim of establishing a reputable high-quality dedicated CRO in Asia.
In 2016 CERC-Asia was set up in Singapore with 2 objectives:
- In the short term, to enhance its interaction with the Asian sites involved in CERC’s global trials by providing them with better guidance and logistical support so that an increasing number of Asian centers may take part in worldwide trials
- In the mid-term, to participate in the development of Clinical Research generated from Asia by drawing on the experience acquired in Europe whilst taking into account local practices.
CERC also provides assistance to investigator-initiated-trials via a dedicated non-profit structure named CERIC.
The Company is ISO 9001 certified and was successfully audited by all major players in the interventional field.
541 Orchard Road
#09-01 Liat Towers